Atlas Trials

Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery

Clinical trial NCT03446911 · UNKNOWN

Trial details

NCT number
NCT03446911
Sponsor
Amsterdam UMC, location VUmc
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
NSCLC, Stage I
Start date
2018-03-01
Primary completion
2020-05-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.